Beijing SL Pharmaceutical Co Ltd (002038) — Cash Flow Quality Index
Beijing SL Pharmaceutical Co Ltd (002038) has a Cash Flow Quality Index of 3.32x as of September 2025. Operating cash flow of CN¥66.55 Million exceeds net income of CN¥20.05 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Beijing SL Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing SL Pharmaceutical Co Ltd Cash Flow Quality Index (2003–2023)
Historical Cash Flow Quality Index for Beijing SL Pharmaceutical Co Ltd across 21 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Beijing SL Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Beijing SL Pharmaceutical Co Ltd (2003–2023)
Year-by-year earnings quality comparison for Beijing SL Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market value of Beijing SL Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.10x | CN¥460.20 Million | CN¥416.69 Million | ▼ -33.6% |
| 2022 | 1.66x | CN¥389.82 Million | CN¥234.40 Million | ▲ +52.5% |
| 2021 | 1.09x | CN¥464.63 Million | CN¥425.94 Million | ▼ -5.2% |
| 2020 | 1.15x | CN¥415.84 Million | CN¥361.45 Million | ▼ -17.1% |
| 2019 | 1.39x | CN¥665.83 Million | CN¥479.50 Million | ▲ +61.2% |
| 2018 | 0.86x | CN¥485.17 Million | CN¥563.39 Million | ▲ +19.6% |
| 2017 | 0.72x | CN¥380.72 Million | CN¥528.76 Million | ▼ -18.8% |
| 2016 | 0.89x | CN¥396.86 Million | CN¥447.39 Million | ▲ +1.4% |
| 2015 | 0.87x | CN¥504.87 Million | CN¥577.22 Million | ▲ +31.9% |
| 2014 | 0.66x | CN¥465.00 Million | CN¥701.05 Million | ▲ +9.2% |
| 2013 | 0.61x | CN¥347.41 Million | CN¥572.01 Million | ▼ -26.9% |
| 2012 | 0.83x | CN¥398.60 Million | CN¥479.98 Million | ▲ +90.5% |
| 2011 | 0.44x | CN¥228.59 Million | CN¥524.39 Million | ▼ -49.4% |
| 2010 | 0.86x | CN¥238.13 Million | CN¥276.39 Million | ▲ +20.4% |
| 2009 | 0.72x | CN¥174.41 Million | CN¥243.75 Million | ▼ -19.6% |
| 2008 | 0.89x | CN¥194.32 Million | CN¥218.43 Million | ▲ +35.7% |
| 2007 | 0.66x | CN¥88.36 Million | CN¥134.82 Million | ▼ -42.7% |
| 2006 | 1.14x | CN¥57.55 Million | CN¥50.34 Million | ▼ -18.5% |
| 2005 | 1.40x | CN¥47.48 Million | CN¥33.84 Million | ▲ +43.6% |
| 2004 | 0.98x | CN¥31.26 Million | CN¥31.99 Million | ▼ -0.2% |
| 2003 | 0.98x | CN¥30.55 Million | CN¥31.20 Million | — |